Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

a experienced a 20 percent tumor reduction. Lastly, a patient with NK/T cell lymphoma had a 75 percent reduction in tumor measurements. Adverse events included two Grade 3 dose- limiting toxicities (upper respiratory infection (URI) and elevated liver enzymes) and five cases of Grade 3 thrombocytopenia (low-platelet count) without any sign of bleeding.

Reductions in platelet counts were analyzed in the three ongoing Phase I trials as a biomarker of Bcl-2 family protein inhibition. Subjects received doses ranging from 10 mg to 315 mg. The study data demonstrate that ABT-263 induces a transient decrease in circulating platelets via inhibition of Bcl- XL, without decreasing platelet production, confirming on-target activity. At 315 mg, researchers observed a 69 percent reduction in mean platelets from baseline values. Typically, platelet nadir occurred on days three to five with recovery during continued dosing. Tumor regression was observed in six patients, with three patients showing more than 50 percent tumor shrinkage. Adverse events included three dose-limiting toxicities, one Grade 3 URI at 160 mg, one Grade 3 alanine aminotransferase (ALT) elevation at 315 mg and one fatal respiratory failure at 10 mg. Updated information will be presented at the ASCO Annual Meeting.

ABT-869

Twenty-four patients from a completed Phase I trial (ABT-869), which studied three dose levels of ABT-869, were evaluated to compare two different measures of angiogenesis using functional imaging -- the distributed parameter (DP) model and the transfer constant (Ktrans) model. DP is a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) model that enables derivation of blood flow and capillary permeability-surface area product (PS). Tests indicated that time over threshold could be an important predictor of efficacy, and results demonstrated that an appropriate value for the plasma concentration threshold could be 0.08 ug/mL, with time above threshold value of
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014 A petition seeking a ban ... in minimally-invasive hysterectomies and fibroid removal surgeries has ... of October, Bernstein Liebhard LLP reports. According to ... November 21st, 2014. That represents an increase of 456 ... on to the campaign.* , The campaign to ban ...
(Date:11/22/2014)... Nov. 22, 2014 (HealthDay News) -- The wide variety ... pose a threat for people with food allergies, an ... are so many types of food allergies that it ... the holidays," Dr. Guha Krishnaswamy, director of allergy and ... in a hospital news release. "If you know ...
(Date:11/22/2014)... 2014 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) ... allegedly developed Type 2 diabetes due to its use ... now underway in U.S. District Court, District of South ... the litigation will convene its next Status Conference on ... Lead Counsel for Plaintiffs and Defendants to meet and ...
(Date:11/22/2014)... 22, 2014 Hastings and Hastings, a ... experience announces providing clients with the option of leaving ... clients a flexible, intuitive and easy to navigate website ... access to Google + allows clients to research the ... a more informed decision when retaining an attorney. Those ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Forbes ... are pleased to announce that Ashley Lombardo and ... #PayItForward contest. , Ms. Lombardo entered friend Candy ... Innovations. She wrote of how her friend is courageously ... as a single mom. Despite medical bills piling up ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2
... MD) In a study published today in the ... from the Kennedy Krieger Institute found differences in the ... Disorder (ADHD). Results showed the region of the brain ... these children than in typically developing children. Novel for ...
... , AUGUSTA, Ga. Researchers want to turn back ... better bone. , Bone-weakening osteoporosis results in a fracture ... Foundation. The right nutrients resulting in the right signals ... stronger bones longer and reducing the death and disability ...
... , THURSDAY, June 9 (HealthDay News) -- A natural compound ... from aging and illness, according to the results of a study ... in apple skin called ursolic acid, according to Dr. Christopher Adams, ... Adams and colleagues first identified 63 genes that change in response ...
... to try to reduce racial and ethnic disparities in the ... the problem at any of the state,s 66 acute-care hospitals, ... effectiveness of the state,s novel approach. While the study, ... (June 9, 2011), found that racial and ethnic inequities for ...
... cardit slips into a wallet or pursebut it could mean the ... MyCare Card stores personal medical data (e.g. information on existing medical ... USB port, enabling the data to be accessed in just a ... type to have been trialled in the UK. This working ...
... WEDNESDAY, June 8 (HealthDay News) -- Brain scans that detect early ... as soon as this year, researchers reported this week, though it ... help for those with the disease. "You,ll get ... people who want to know what,s going on when their memory ...
Cached Medicine News:Health News:Brain imaging study of preschoolers with ADHD detects brain differences linked to symptoms 2Health News:Researchers work to turn back the clock on bone-producing stem cells 2Health News:Researchers work to turn back the clock on bone-producing stem cells 3Health News:Researchers work to turn back the clock on bone-producing stem cells 4Health News:Apples Help Keep Muscles Strong, Mouse Study Finds 2Health News:Pioneering hospital pay-for-performance program falls short of its goals 2Health News:MyCare -- the 'card' that could save your life 2Health News:Brain Scans to Spot Alzheimer's May Be Available This Year 2
(Date:11/22/2014)... CHAPEL HILL, N.C. , Nov. 21, 2014 ... the healthcare system. Undoubtedly, the growing influence of ... and spend for marketing interactions. Now, more than ... and retain patients for medical products is essential. ... benchmarking firm, Best Practices, LLC, benchmarked companies spent ...
(Date:11/21/2014)... , Nov. 21, 2014  Tandem Diabetes Care ... a medical device company and manufacturer of the ... partnership with Tidepool, a non-profit dedicated to improving ... software platform that increases diabetes data accessibility. This ... which is currently under development, to download and ...
(Date:11/21/2014)... 2014  Heated dialogue in recent months about the ... treatments to Gilead,s new hepatitis C drug Harvoni® – ... questioning what it means to put a price on ... And while drug pricing is one of the most ... a general business and ethical standpoint – it is ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... and JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a privately ... CEO, will present an overview of the Company at the ... York, New York, on Monday, September 19, 2011 at 1:30 ... oral form of octreotide acetate being developed first for the ...
... Medical Technologies, Inc. and the Physician Services technology ... announced an agreement for INHS to provide Greenway,s ... solution PrimeSUITE® 2011 to hospital systems ... network interoperability. Established more than a ...
Cached Medicine Technology:Chiasma to Present at the UBS Global Life Sciences Conference 2Greenway Partners With INHS to Advance EHR Adoption 2Greenway Partners With INHS to Advance EHR Adoption 3
... a test for the presence of blood is ... in guaiac to quinones, resulting in the production ... the heme portion of the hemoglobin molecule can ... of oxygen from hydrogen peroxide which in turn ...
... years, the Hemoccult fecal occult blood test (FOBT) ... in stool specimens as an early indication of ... products many of which were conducted over ... participants- have been published in leading medical journals ...
... scientific principles supporting the effectiveness and accuracy ... upon extensive clinical studies. As a woman ... estrogen level increases, thereby, elevating the salt ... as saliva is allowed to dry, crystalization ...
Inquire...
Medicine Products: